TNF, JAK Inhibitors' CV Safety Compared in PsA, AxSpA
JAK inhibitors were not associated with higher risk of myocardial infarction or stroke and venous thromboembolism, compared with TNF-inhibitor users, in a small study.
Source: medscape.com